Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
38%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
17%
ALSO IN PPH
PPH
26
HOLDINGS
43%
ALSO IN XLV
SECTOR DRIFT (XLV minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in PPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 11.2% | 16.7% | 11.2% | |
JOHNSON & JOHNSON | 8.6% | 11.6% | 8.6% | |
ABBVIE INC | 7.4% | 5.0% | 5.0% | |
MERCK & CO. INC. | 4.4% | 6.4% | 4.4% | |
PFIZER INC | 2.9% | 4.8% | 2.9% |
XLV Overweight Relative to PPH
UNITEDHEALTH GROUP INC | 5.6% | |
ABBOTT LABORATORIES | 4.6% | |
THERMO FISHER SCIENTIFIC INC | 3.8% | |
INTUITIVE SURGICAL INC | 3.4% | |
AMGEN INC | 3.2% | |
BOSTON SCIENTIFIC CORP | 3.1% | |
GILEAD SCIENCES INC | 2.8% | |
STRYKER CORP | 2.7% | |
DANAHER CORP | 2.7% | |
ABBVIE INC | 2.4% |
XLV Underweight Relative to PPH
NOVARTIS AG-ADR | -7.9% | |
NOVO-NORDISK A/S-SPONS ADR | -6.1% | |
ELI LILLY & CO | -5.5% | |
ASTRAZENECA PLC-SPONS ADR | -5.0% | |
SANOFI-AVENTIS-ADR | -4.7% | |
GLAXOSMITHKLINE PLC-SPON ADR | -4.4% | |
JOHNSON & JOHNSON | -3.0% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.9% | |
ZOETIS INC | -2.9% | |
CENCORA INC | -2.7% |